Delivery Order SPE2DB24D1205-SPE2DB25FCWZB
Award Date
5/21/25
Potential Completion Date
6/12/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $93,868.32, is for the delivery of 4,568,082,632 vials of the medication XEOMIN 200 UNIT. The contract has an ultimate completion date of May 20, 2025 and was awarded on April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,174.80, is a delivery order for 4,567,960,815 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 8, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,676.22, is for the delivery of 4,568,073,926 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The award has a period of performance through May 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,252,862 units of XEOMIN 200 UNIT VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $16,762.20 and a period of performance through June 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,539,303 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The contract has a completion date of February 26, 2024, and a potential value of $1,048.48. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
This federal contract award, valued at $2,793.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,093,142 units of XEOMIN 100 UNIT VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of February 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,097,248 units of XEOMIN 200 unit vials, a pharmaceutical product, at a firm fixed price of $16,762.20. The contract has an ultimate completion date of May 21, 2025 and was awarded on April 30, 2025. This delivery order is part of a larger Indefinite Delivery...
This is a $78,637.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,703,883 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a period of performance through September 25, 2024. This delivery order contract is placed against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,879,382 units of the medication XEOMIN 200 UNIT VIALS, with a firm fixed price of $13,968.50 and a performance period through May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,912,777 units of XEOMIN 100 Unit Vials, a pharmaceutical product, at a ceiling value of $5,587.40. The contract is a firm fixed-price, non-set-aside procurement with a completion date of May 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery...